Cover Image

Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin

Clinical trials of biologic agents for chronic active antibody-mediated rejection (CAMR) in kidney transplant recipients (KTRs) have been disappointing. We performed a clinical trial of mesenchymal stem cell (MSC) treatment in KTRs with CAMR unresponsive to rituximab and intravenous immunoglobulin....

Full description

Saved in:

Bibliographic Details
Main Authors:	Tae Hyun Ban (Author), Sua Lee (Author), Hyung Duk Kim (Author), Eun Jeong Ko (Author), Bo-Mi Kim (Author), Kyoung-Woon Kim (Author), Byung Ha Chung (Author), Chul Woo Yang (Author)
Format:	Book
Published:	Hindawi Limited, 2021-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection
by: Yaeni Kim, et al.
Published: (2014)

Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
by: Euri Seo, et al.
Published: (2016)

Successful treatment of recalcitrant juvenile pemphigus foliaceus with intravenous immunoglobulin and rituximab
by: Hock Gin Teo, et al.
Published: (2022)

Rituximab monotherapy in precursor-B-Cell acute Lymphoblastic leukaemia: Managing relapse or graft rejection post-allogenic bone marrow transplant
by: Rachit Khandelwal, et al.
Published: (2024)

Mesenchymal stem cells avoid allogeneic rejection
by: Murphy J Mary, et al.
Published: (2005)

A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease
by: Yuji Amano, et al.
Published: (2019)

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab
by: Knight T, et al.
Published: (2017)

Severe Anemia Due to Parvovirus Infection Following Treatment with Rituximab in a Pediatric Kidney Transplant Recipient : Anemia after Treatment of Rituximab in Kidney Recipient Patient
by: Seung Yun Kim, et al.
Published: (2015)

Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients
by: Marita Prohn, et al.
Published: (2021)

Salmonella Encephalopathy Treated with Early Use of Intravenous Immunoglobulin and Dexamethasone
by: Geon Hui Kim, et al.
Published: (2020)

Use of intravenous immunoglobulin in a disseminated varicella infection in an immunocompromised child
by: Jae Hong Kim, et al.
Published: (2014)

Intravenous immunoglobulin in dermatology
by: Dhar Sandipan
Published: (2009)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRICS
by: A.Yu. Shcherbina, et al.
Published: (2010)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRICS
by: A.Yu. Shcherbina, et al.
Published: (2010)

A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo
by: Senthil Jayarajan, et al.
Published: (2022)

Impact of high body mass index on allograft outcomes in kidney transplant recipients with presensitization to human leukocyte antigen
by: Yohan Park, et al.
Published: (2021)

Efficacy of add‐on therapy with intravenous immunoglobulin in steroid hyporesponsive DRESS syndrome
by: Da Woon Sim, et al.
Published: (2022)

Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients
by: Woo Yeong Park, et al.
Published: (2021)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
by: Hyo Min Park, et al.
Published: (2013)

Remission of Anti-laminin 332 Mucous Membrane Pemphigoid Associated with Non-small Cell Lung Cancer after Therapy with Rituximab and Intravenous Immunoglobulin
by: Evelyne Tarnowietzki, et al.
Published: (2020)

Therapies for Chronic Allograft Rejection
by: Min Young Kim, et al.
Published: (2021)

Kidney transplantation in highly sensitized recipients
by: Yohan Park, et al.
Published: (2021)

Effect of Blocking with Minicircle DNA of Interleukin-6 on Skin Allograft Rejection
by: Doh Kyoung Chan, et al.
Published: (2014)

INTRAVENOUS IMMUNOGLOBULIN THERAPY IN MEDICAL PRAXIS
by: Lidija Kareva
Published: (2016)

Prurigo nodularis responding to intravenous immunoglobulins
by: Koray Durmaz, et al.
Published: (2022)

Pemphigoid gestationis and intravenous immunoglobulin therapy
by: Anes Yang, MD, BMed, MPH, et al.
Published: (2018)

Intravenous immunoglobulin: Revisited - My experience
by: Sanjeev S Vaishampayan, et al.
Published: (2021)

Use of intravenous immunoglobulins in clinical practice
by: E.K. Donyush
Published: (2011)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015)

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE
by: T. V. Latysheva, et al.
Published: (2013)

Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013)

Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013)

Use of intravenous immunoglobulins in clinical practice
by: E.K. Donyush
Published: (2011)

Shifts in Intestinal Metabolic Profile Among Kidney Transplantation Recipients with Antibody-Mediated Rejection
by: Wang J, et al.
Published: (2023)

Single dose thymoglobulin induction therapy in prevention of acute rejection in renal transplant recipients
by: Georgi Abraham, et al.
Published: (2018)

The fate of manuscripts rejected from Kidney Research and Clinical Practice
by: Sungjin Chung, et al.
Published: (2020)

Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis
by: Wee Leng Gan, et al.
Published: (2018)

Cost-Effectiveness of Targeted Prophylaxis among Allogenic Stem Cell Transplant Recipients
by: Nour Shbaklo, et al.
Published: (2023)

The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center
by: Young Jun Ko, et al.
Published: (2020)

Changing pattern and safety of pretransplant malignancy in kidney transplant recipients
by: Tae Hyun Ban, et al.
Published: (2019)